Methylene blue–induced serotonin syndrome after left ventricular assist device implantation: A case report and literature review

Journal of Thoracic and Cardiovascular Surgery

Volumn 154, Issue 3, 2017, Pages e39-e43

  Schumacher, Leif Erik D ^a   Blumer, Vanessa ^b   Chaparro, Sandra V ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

^c UNIVERSITY OF MIAMI HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPINEPHRINE; LORAZEPAM; METHYLENE BLUE; MILRINONE; NORADRENALIN; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CORONARY ARTERY DISEASE; DISEASE EXACERBATION; DISEASE SEVERITY; HEART FAILURE; HUMAN; IMPLANTATION; INOTROPISM; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR ASSIST DEVICE; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; PRIORITY JOURNAL; SEROTONIN SYNDROME; CHEMICALLY INDUCED; DRUG POTENTIATION; HEART ASSIST DEVICE; POSTOPERATIVE COMPLICATION; THORAX SURGERY;

CITALOPRAM; DRUG SYNERGISM; HEART-ASSIST DEVICES; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; THORACIC SURGICAL PROCEDURES;

EID: 85021188933     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2017.05.053     Document Type: Article

References (25)

1. Shanmugam, G., Kent, B., Baskett, R., Serotonin syndrome following cardiac surgery. Interact Cardiovasc Thorac Surg 7 (2008), 656–657.
2. Choudhury, M., Hote, M.P., Verma, Y., Serotonin syndrome in a postoperative patient. J Anaesthesiol Clin Pharmacol 27 (2011), 233–235.
3. Grubb, K.J., Kennedy, J.L., Bergin, J.D., Groves, D.S., Kern, J.A., The role of methylene blue in serotonin syndrome following cardiac transplantation: a case report and review of the literature. J Thorac Cardiovasc Surg 144 (2012), e113–e116.
4. Fugate, J.E., White, R.D., Rabinstein, A.A., Serotonin syndrome after therapeutic hypothermia for cardiac arrest: a case series. Resuscitation 85 (2014), 774–777.
5. Hanna, E.R., Clark, J.A., Serotonin syndrome after cardiopulmonary bypass: a case demonstrating the interaction between methylene blue and selective serotonin reuptake inhibitors. A A Case Rep 2 (2014), 113–114.
6. Smith, C.J., Wang, D., Sgambelluri, A., Kramer, R.S., Gagnon, D.J., Serotonin syndrome following methylene blue administration during cardiothoracic surgery. J Pharm Pract 28 (2015), 207–211.
7. Hencken, L., To, L., Ly, N., Morgan, J.A., Serotonin syndrome following methylene blue administration for vasoplegic syndrome. J Card Surg 31 (2016), 208–210.
8. Martino, E.A., Winterton, D., Nardelli, P., Pasin, L., Calabrò, M.G., Bove, T., et al. The blue coma: the role of methylene blue in unexplained coma after cardiac surgery. J Cardiothorac Vasc Anesth 30 (2016), 423–427.
9. Wolvetang, T., Janse, R., Ter Horst, M., Serotonin syndrome after methylene blue administration during cardiac surgery: a case report and review. J Cardiothorac Vasc Anesth 30 (2016), 1042–1045.
10. Broussard, D., Donaldson, E., Falterman, J., Bates, M., Anesthesia for left ventricular assist device insertion: a case series and review. Ochsner J 11 (2011), 70–77.
11. Ailawadhi, S., Sung, K.W., Carlson, L.A., Baer, M.R., Serotonin syndrome caused by interaction between citalopram and fentanyl. J Clin Pharm Ther 32 (2007), 199–202.
12. Hosseinian, L., Weiner, M., Levin, M.A., Fischer, G.W., Methylene blue: magic bullet for vasoplegia?. Anesth Analg 122 (2016), 194–201.
13. Levin, R.L., Degrange, M.A., Bruno, G.F., Del Mazo, C.D., Taborda, D.J., Griotti, J.J., et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 77 (2004), 496–499.
14. Argenziano, M., Chen, J.M., Choudhri, A.F., Cullinane, S., Garfein, E., Weinberg, A.D., et al. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 116 (1998), 973–980.
15. Weiner, M.M., Lin, H.M., Danforth, D., Rao, S., Hosseinian, L., Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth 27 (2013), 1233–1238.
16. Evora, P.R., Ribeiro, P.J., Vicente, W.V., Reis, C.L., Rodrigues, A.J., Menardi, A.C., et al. Methylene blue for vasoplegic syndrome treatment in heart surgery: Fifteen years of questions, answers, doubts and certainties. Rev Bras Cir Cardiovasc 24 (2009), 279–288.
17. Oz, M., Lorke, D.E., Hasan, M., Petroianu, G.A., Cellular and molecular actions of methylene blue in the nervous system. Med Res Rev 31 (2011), 93–117.
18. Tousoulis, D., Antonopoulos, A.S., Antoniades, C., Saldari, C., Stefanadi, E., Siasos, G., et al. Role of depression in heart failure—choosing the right antidepressive treatment. Int J Cardiol 140 (2009), 12–18.
19. Harris, J., Heil, J.S., Managing depression in patients with advanced heart failure awaiting transplantation. Am J Health Syst Pharm 70 (2013), 867–873.
20. Thomas, S.A., Chapa, D.W., Friedmann, E., Durden, C., Ross, A., Lee, M.C.Y., et al. Depression in patients with heart failure: prevalence, pathophysiological mechanisms, and treatment. Crit Care Nurse 28 (2008), 40–55.
21. Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L.H., Cuffe, M.S., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161 (2001), 1849–1856.
22. Dunkley, E.J.C., Isbister, G.K., Sibbritt, D., Dawson, A.H., Whyte, I.M., The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 96 (2003), 635–642.
23. Boyer, E.W., Shannon, M., The serotonin syndrome. N Engl J Med 352 (2005), 1112–1120.
24. Ables, A.Z., Nagubilli, R., Prevention, diagnosis, and management of serotonin syndrome. Am Fam Physician 81 (2010), 1139–1142.
25. Frank, C., Recognition and treatment of serotonin syndrome. Can Fam Physician 54 (2008), 988–992.